OPTIMISING PALLIATIVE CARE FOR FRAIL ELDERS IN COMMUNITY SETTINGS; PREFERENCES FOR CARE AND PALLIATIVE OUTCOMES IN THE LAST MONTHS OF LIFE

2014 ◽  
Vol 4 (1) ◽  
pp. 111.4-112 ◽  
Author(s):  
CJ Evans ◽  
A Bone ◽  
M Morgan ◽  
P McCrone ◽  
W Gaoi ◽  
...  
ESC CardioMed ◽  
2018 ◽  
pp. 1908-1911
Author(s):  
James Beattie

From an evolutionary base in the care of those with cancer, the potential benefits of palliative care for those affected by other life-limiting diseases such as heart failure have been widely recognized. People with heart failure are subject to a symptom burden and mortality risk similar to those associated with malignant disease, but the clinical scenario is often more complicated. This relatively aged clinical population tend to have multiple co-morbidities and an unpredictable disease trajectory. The beneficial but increasingly complex nature of comprehensive heart failure therapy in polypharmacy, implantable devices, and cardiac surgical intervention may undermine clinical coordination, patient autonomy, and ultimately conflict with patients’ and families’ changing preferences for care along a progressive disease course to the end of life. This chapter describes the challenges and opportunities in providing palliative care to this burgeoning clinical cohort.


2018 ◽  
Vol 35 (12) ◽  
pp. 1477-1482 ◽  
Author(s):  
Elissa Kozlov ◽  
Anna Cai ◽  
Jo Anne Sirey ◽  
Angela Ghesquiere ◽  
M. Carrington Reid

Though palliative care is appropriate for patients with serious illness at any stage of the illness and treatment process, the vast majority of palliative care is currently delivered in inpatient medical settings in the past month of life during an acute hospitalization. Palliative care can have maximal benefit to patients when it is integrated earlier in the illness trajectory. One possible way to increase earlier palliative care use is to screen for unmet palliative care needs in community settings. The goal of this study was to assess the rates of unmet palliative care needs in older adults who attend New York City–based senior centers. The results of this study revealed that 28.8% of participants screened positive for unmet palliative care needs. Lower education and living alone were predictors of positive palliative care screens, but age, gender, marital status, and race were not. This study determined that the rate of unmet palliative care needs in community-based older adults who attend senior center events was high and that living arrangement and education level are both correlates of unmet palliative care needs. Screening for unmet palliative care needs in community settings is a promising approach for moving palliative care upstream to patients who could benefit from the additional supportive services prior to an acute hospitalization.


2011 ◽  
Vol 7 (6) ◽  
pp. 361-366 ◽  
Author(s):  
Sangeeta C. Ahluwalia ◽  
Fukai L. Chuang ◽  
Anna Liza M. Antonio ◽  
Jennifer L. Malin ◽  
Karl A. Lorenz ◽  
...  

Providers may need help identifying patients for appropriate palliative care services earlier in their trajectory.


BMJ Open ◽  
2018 ◽  
Vol 8 (3) ◽  
pp. e020071 ◽  
Author(s):  
Ping Guo ◽  
Mendwas Dzingina ◽  
Alice M Firth ◽  
Joanna M Davies ◽  
Abdel Douiri ◽  
...  

IntroductionProvision of palliative care is inequitable with wide variations across conditions and settings in the UK. Lack of a standard way to classify by case complexity is one of the principle obstacles to addressing this. We aim to develop and validate a casemix classification to support the prediction of costs of specialist palliative care provision.Methods and analysisPhase I: A cohort study to determine the variables and potential classes to be included in a casemix classification. Data are collected from clinicians in palliative care services across inpatient hospice, hospital and community settings on: patient demographics, potential complexity/casemix criteria and patient-level resource use. Cost predictors are derived using multivariate regression and then incorporated into a classification using classification and regression trees. Internal validation will be conducted by bootstrapping to quantify any optimism in the predictive performance (calibration and discrimination) of the developed classification. Phase II: A mixed-methods cohort study across settings for external validation of the classification developed in phase I. Patient and family caregiver data will be collected longitudinally on demographics, potential complexity/casemix criteria and patient-level resource use. This will be triangulated with data collected from clinicians on potential complexity/casemix criteria and patient-level resource use, and with qualitative interviews with patients and caregivers about care provision across difference settings. The classification will be refined on the basis of its performance in the validation data set.Ethics and disseminationThe study has been approved by the National Health Service Health Research Authority Research Ethics Committee. The results are expected to be disseminated in 2018 through papers for publication in major palliative care journals; policy briefs for clinicians, commissioning leads and policy makers; and lay summaries for patients and public.Trial registration numberISRCTN90752212.


2011 ◽  
Vol 29 (6) ◽  
pp. 755-760 ◽  
Author(s):  
Jeffrey M. Peppercorn ◽  
Thomas J. Smith ◽  
Paul R. Helft ◽  
David J. DeBono ◽  
Scott R. Berry ◽  
...  

Patients with advanced incurable cancer face complex physical, psychological, social, and spiritual consequences of disease and its treatment. Care for these patients should include an individualized assessment of the patient's needs, goals, and preferences throughout the course of illness. Consideration of disease-directed therapy, symptom management, and attention to quality of life are important aspects of quality cancer care. However, emerging evidence suggests that, too often, realistic conversations about prognosis, the potential benefits and limitations of disease-directed therapy, and the potential role of palliative care, either in conjunction with or as an alternative to disease-directed therapy, occur late in the course of illness or not at all. This article addresses the American Society of Clinical Oncology's (ASCO's) vision for improved communication with and decision making for patients with advanced cancer. This statement advocates an individualized approach to discussing and providing disease-directed and supportive care options for patients with advanced cancer throughout the continuum of care. Building on ASCO's prior statements on end-of-life care (1998) and palliative care (2009), this article reviews the evidence for improved patient care in advanced cancer when patients' individual goals and preferences for care are discussed. It outlines the goals for individualized care, barriers that currently limit realization of this vision, and possible strategies to overcome these barriers that can improve care consistent with the goals of our patients and evidence-based medical practice.


Sign in / Sign up

Export Citation Format

Share Document